BMY

Bristol Myers Squibb

Health Care

Pharmaceuticals

New York City, New York

Balance Sheet 35 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Assets - CashAndCashEquivalents	$10.3B	$11.5B	$9.1B	$14.0B	$14.5B
Assets - AccountsReceivable	$9.0B	$8.9B	$8.2B	$8.0B	$7.2B
Assets - Inventories	$2.6B	$2.7B	$2.3B	$2.1B	$2.1B
Assets - PrepaidExpensesAndOtherCurrentAssets	$5.6B	$5.9B	$5.8B	$4.8B	$3.8B
Assets - TotalCurrentAssets	$29.8B	$31.8B	$27.3B	$33.3B	$30.2B
Assets - Property,PlantAndEquipment	$7.1B	$6.6B	$6.3B	$6.0B	$5.9B
Assets - Goodwill	$21.7B	$21.2B	$21.1B	$20.5B	$20.5B
Assets - IntangibleAssets(net,ExcludingGoodwill)	$23.3B	$27.1B	$35.9B	$42.5B	$53.2B
Assets - OperatingLeaseAssets	$1.2B	$1.4B	$1.2B	$919.0M	$859.0M
Assets - DeferredTaxAssets	$8.4B	$7.3B	$4.1B	$2.7B	$3.5B
Assets - OtherNoncurrentAssets	$6.1B	$5.4B	$4.9B	$5.5B	$7.0B
Assets - TotalAssets	$92.6B	$95.2B	$96.8B	$109.3B	$118.5B
Liabilities - AccountsPayable	$3.6B	$3.3B	$3.0B	$2.9B	$2.7B
Liabilities - AccruedLiabilities	$2.0B	$2.1B	$2.1B	$1.9B	$2.2B
Liabilities - ShortTermDebtAndCurrentPortionOfLongTermDebt	$2.0B	$3.1B	$4.3B	$4.9B	$2.3B
Liabilities - OperatingLeaseLiabilitiesCurrent	$181.0M	$162.0M	$136.0M	$169.0M	$164.0M
Liabilities - OtherCurrentLiabilities	$18.1B	$15.9B	$14.6B	$14.0B	$14.0B
Liabilities - TotalCurrentLiabilities	$23.8B	$22.3B	$21.9B	$21.9B	$19.1B
Liabilities - LongTermDebt	$47.6B	$36.7B	$35.1B	$39.6B	$48.3B
Liabilities - OperatingLeaseLiabilitiesNoncurrent	$1.4B	$1.5B	$1.3B	$874.0M	$833.0M
Liabilities - DeferredTaxLiabilitiesNoncurrent	$369.0M	$338.0M	$2.2B	$4.5B	$5.4B
Liabilities - PensionAndPostretirementBenefitLiabilitiesNoncurrent	$400.0M	$480.0M	$402.0M	$654.0M	$899.0M
Liabilities - OtherNoncurrentLiabilities	$4.5B	$6.4B	$6.6B	$7.3B	$7.8B
Liabilities - TotalLiabilities	$76.2B	$65.7B	$65.7B	$73.3B	$80.6B
Equity - PreferredStock	$0	$0	$0	$0	$0
Equity - CommonStock	$7.4B	$7.4B	$292.0M	$292.0M	$292.0M
Equity - AdditionalPaidInCapital	$46.0B	$45.7B	$45.2B	$44.4B	$44.3B
Equity - RetainedEarnings(deficit)	$14.9B	$28.8B	$25.5B	$23.8B	$21.3B
Equity - AccumulatedOtherComprehensiveIncome(loss)	$-1.2B	$-1.5B	$-1.3B	$-1.3B	$-1.8B
Equity - NoncontrollingInterest(permanentEquity)	$53.0M	$55.0M	$57.0M	$60.0M	$60.0M
Equity - TotalStockholdersEquity	$16.3B	$29.4B	$31.1B	$35.9B	$37.8B
Equity - TotalLiabilitiesAndStockholdersEquity	$92.6B	$95.2B	$96.8B	$109.3B	$118.5B
Equity - TotalLiabilitiesandEquity	$92.5B	$95.1B	$96.8B	$109.3B	$118.4B
Validation - L+E Components Sum Difference	$0	$0	$0	$0	$0

Income Statement 25 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
IncomeStatement - Revenues - NetProductSales/Revenues	$48.3B	$45.0B	$46.2B	$46.4B	$42.5B
IncomeStatement - CostsAndExpenses - CostOfGoodsSold	$14.0B	$10.7B	$10.1B	$9.9B	$11.8B
IncomeStatement - CostsAndExpenses - ResearchAndDevelopmentExpense	$11.2B	$9.3B	$9.5B	$10.2B	$10.0B
IncomeStatement - CostsAndExpenses - Selling,GeneralAndAdministrative(andMarketing)	$8.4B	$7.8B	$7.8B	$7.7B	$7.7B
IncomeStatement - CostsAndExpenses - AmortizationOfIntangibleAssets(operating)	$9.0B	$9.2B	$9.7B	$10.2B	$9.9B
IncomeStatement - CostsAndExpenses - Depreciation(operating)	$651.0M	$611.0M	$587.0M	$559.0M	$586.0M
IncomeStatement - CostsAndExpenses - RestructuringAndImpairmentCharges	$635.0M	$365.0M	$75.0M	$169.0M	$530.0M
IncomeStatement - CostsAndExpenses - AcquisitionAndIntegrationCosts	$284.0M	$242.0M	$440.0M	$0	$0
IncomeStatement - OtherIncomeExpense - InterestIncome	$478.0M	$449.0M	$171.0M	$39.0M	$121.0M
IncomeStatement - OtherIncomeExpense - Gain(loss)OnInvestments/EquityMethod	$16.0M	$-160.0M	$-801.0M	$745.0M	$1.2B
IncomeStatement - OtherIncomeExpense - Gain(loss)OnExtinguishmentOfDebt	$0	$0	$-266.0M	$-281.0M	$0
IncomeStatement - OtherIncomeExpense - Gain(loss)OnDivestitures/saleOfAssets	$-15.0M	$0	$211.0M	$9.0M	$55.0M
IncomeStatement - OtherIncomeExpense - LitigationSettlements(gain/loss)	$-84.0M	$390.0M	$-178.0M	$-82.0M	$194.0M
IncomeStatement - OtherIncomeExpense - OtherNonoperatingIncome(expense)	$-893.0M	$1.2B	$-576.0M	$720.0M	$2.3B
IncomeStatement - OtherIncomeExpense - Income(loss)FromContinuingOperationsBeforeIncomeTaxes	$-8.4B	$8.4B	$7.7B	$8.1B	$-6.9B
IncomeStatement - IncomeTax - IncomeTaxExpense(benefit)	$554.0M	$400.0M	$1.4B	$1.1B	$2.1B
IncomeStatement - IncomeTax - EffectiveTaxRate(continuingOperations)	$-0	$0	$0	$0	$-0
IncomeStatement - NetIncomeAndEps - NetIncome(loss)	$-8.9B	$8.0B	$6.3B	$7.0B	$-9.0B
IncomeStatement - NetIncomeAndEps - NetIncome(loss)AttributableToCompany	$-8.9B	$8.0B	$6.3B	$7.0B	$-9.0B
IncomeStatement - NetIncomeAndEps - BasicEarningsPerShare	$-4	$4	$3	$3	$-4
IncomeStatement - NetIncomeAndEps - DilutedEarningsPerShare	$-4	$4	$3	$3	$-4
IncomeStatement - NetIncomeAndEps - WeightedAverageSharesOutstandingBasic	$2.0B	$2.1B	$2.1B	$2.2B	$2.3B
IncomeStatement - NetIncomeAndEps - WeightedAverageSharesOutstandingDiluted	$2.0B	$2.1B	$2.1B	$2.2B	$2.3B
IncomeStatement - NetIncomeAndEps - ComprehensiveIncome(loss)	$-8.6B	$7.8B	$6.3B	$7.6B	$-9.3B

Cash Flow Statement 26 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
CashFlow - OperatingActivities - NetIncome	$-8.9B	$8.0B	$6.3B	$7.0B	$-9.0B
CashFlow - OperatingActivities - DepreciationAndAmortization	$9.6B	$9.8B	$10.3B	$10.7B	$10.4B
CashFlow - OperatingActivities - ShareBasedCompensation	$507.0M	$518.0M	$457.0M	$583.0M	$779.0M
CashFlow - OperatingActivities - DeferredIncomeTaxes	$-2.1B	$-3.3B	$-2.7B	$-1.4B	$983.0M
CashFlow - OperatingActivities - ProvisionForDoubtfulAccounts	$41.0M	$14.0M	$7.0M	$4.0M	$12.0M
CashFlow - OperatingActivities - Gain/lossOnSale/disposalOfAssets/businesses(nonCashAdj.)	$16.0M	$-160.0M	$-801.0M	$745.0M	$1.2B
CashFlow - OperatingActivities - ChangesInOperatingAssetsAndLiabilities	$-624.0M	$667.0M	$610.0M	$265.0M	$111.0M
CashFlow - OperatingActivities - NetCashFromOperatingActivities(continuingOperations)	$15.2B	$13.9B	$13.1B	$16.2B	$14.1B
CashFlow - InvestingActivities - CapitalExpenditures(pp&e&Intangibles)	$1.2B	$1.2B	$1.1B	$973.0M	$753.0M
CashFlow - InvestingActivities - AcquisitionsOfBusinesses,NetOfCash	$21.8B	$1.2B	$4.3B	$1.6B	$13.1B
CashFlow - InvestingActivities - PurchasesOfMarketableSecurities/investments	$769.0M	$1.8B	$3.6B	$5.5B	$4.2B
CashFlow - InvestingActivities - ProceedsFromSales/maturitiesOfMarketableSecurities/investments	$1.1B	$733.0M	$6.4B	$4.2B	$6.3B
CashFlow - InvestingActivities - ProceedsFromDivestitureOfBusinesses/assets	$1.1B	$858.0M	$1.2B	$748.0M	$715.0M
CashFlow - InvestingActivities - NetCashFromInvestingActivities(continuingOperations)	$-21.4B	$-2.3B	$-1.1B	$-538.0M	$-10.9B
CashFlow - FinancingActivities - ProceedsFromIssuanceOfDebt	$12.9B	$4.5B	$5.9B	$0	$6.9B
CashFlow - FinancingActivities - RepaymentsOfDebt	$2.9B	$3.9B	$11.4B	$6.0B	$2.8B
CashFlow - FinancingActivities - PaymentsForRepurchaseOfCommonStock	$0	$5.2B	$8.0B	$6.3B	$1.5B
CashFlow - FinancingActivities - PaymentOfDividends	$4.9B	$4.7B	$4.6B	$4.4B	$4.1B
CashFlow - FinancingActivities - OtherFinancingActivities	$520.0M	$27.0M	$984.0M	$641.0M	$542.0M
CashFlow - FinancingActivities - NetCashFromFinancingActivities(continuingOperations)	$5.1B	$-9.4B	$-17.0B	$-16.2B	$-1.2B
CashFlow - CashReconciliationAndSupplemental - EffectOfExchangeRateChangesOnCash	$-137.0M	$45.0M	$-33.0M	$-102.0M	$111.0M
CashFlow - CashReconciliationAndSupplemental - NetChangeInCash	$-1.2B	$2.2B	$-5.0B	$-657.0M	$2.2B
CashFlow - CashReconciliationAndSupplemental - IncomeTaxesPaid	$3.9B	$4.3B	$5.4B	$3.5B	$3.4B
CashFlow - CashReconciliationAndSupplemental - InterestPaid	$1.8B	$1.2B	$1.4B	$1.5B	$1.6B
CashFlow - CashReconciliationAndSupplemental - RightOfUseAssetsObtainedForLeases(nonCash)	$22.0M	$389.0M	$492.0M	$228.0M	$326.0M

Bristol Myers Squibb

Balance Sheet 35 Accounts • 5 Years

Income Statement 25 Accounts • 5 Years

Cash Flow Statement 26 Accounts • 5 Years

Stock Market Data (1 Year) Live Yahoo Finance Data

Recent Price History